McIlrath & Eck’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.5K Hold
232
﹤0.01% 622
2025
Q4
$37.3K Hold
232
﹤0.01% 399
2025
Q3
$30.7K Hold
232
﹤0.01% 417
2025
Q2
$22.3K Hold
232
﹤0.01% 460
2025
Q1
$23.8K Hold
232
﹤0.01% 450
2024
Q4
$24K Buy
232
+192
+480% +$20.7K ﹤0.01% 449
2024
Q3
$4.42K Sell
40
-192
-83% -$18.6K ﹤0.01% 764
2024
Q2
$20.4K Hold
232
﹤0.01% 451
2024
Q1
$17.7K Buy
232
+192
+480% +$15K ﹤0.01% 491
2023
Q4
$3.46K Buy
+40
New +$3.35K ﹤0.01% 750

Other funds holding CHRW

McIlrath & Eck's CHRW Position: Q1 2026 in Review

McIlrath & Eck held its C.H. Robinson (CHRW) position steady in Q1 2026 at 232 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #622.

McIlrath & Eck first reported a position in CHRW in Q4 2023 and has held it in 10 quarters since. 889 funds tracked by Wall St. Rank hold CHRW as of Q1 2026.

  • McIlrath & Eck held 232 shares of C.H. Robinson worth $38.5K as of Q1 2026.
  • McIlrath & Eck left its C.H. Robinson share count unchanged in Q1 2026.
  • C.H. Robinson made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #622 holding.
  • McIlrath & Eck first reported a position in C.H. Robinson in Q4 2023 and has held it in 10 quarters since.
  • 889 funds tracked by Wall St. Rank held C.H. Robinson as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.